|
96
|
301
|
8osxA |
Sars-cov-2 nsp10-16 methyltransferase in complex with atp |
|
27
|
153
|
7zw5B |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2259 |
|
0
|
38
|
7zw5A |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2259 |
|
95
|
301
|
8otrA |
Sars-cov-2 nsp10-16 methyltransferase in complex with sam analog bdh 33959089 |
|
27
|
116
|
8otrB |
Sars-cov-2 nsp10-16 methyltransferase in complex with sam analog bdh 33959089 |
|
0
|
39
|
7zvvA |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2196 |
|
28
|
154
|
7zvvB |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2196 |
|
81
|
306
|
8dk8A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
96
|
311
|
8fwnA |
Crystal structure of sars-cov-2 papain-like protease c111s mutant |
|
61
|
167
|
8giaA |
Crystal structure of sars-cov-2 (covid-19) nsp3 macrodomain in complex with tfmu-adpr |
|
89
|
306
|
8dl9A |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound z199538122 |
|
88
|
306
|
8dmdA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound zz4461624291 |
|
88
|
306
|
8dlbA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with compound z2799209083 |
|
90
|
301
|
8ov1A |
Sars-cov-2 nsp10-16 methyltransferase in complex with adp |
|
89
|
301
|
8ov4A |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin |
|
92
|
301
|
8ov2A |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin |
|
25
|
116
|
8ov1B |
Sars-cov-2 nsp10-16 methyltransferase in complex with adp |
|
27
|
115
|
8ot0B |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta and glycine |
|
96
|
301
|
8ot0A |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta and glycine |
|
27
|
114
|
8ov2B |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin |
|
25
|
116
|
8ov4B |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin |
|
26
|
115
|
8ov3B |
Sars-cov-2 nsp10-16 methyltransferase in complex with 5-iodotubercidin |
|
88
|
300
|
8ov3A |
Sars-cov-2 nsp10-16 methyltransferase in complex with 5-iodotubercidin |
|
80
|
301
|
8okkA |
Crystal structure of f2f-2020184-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
24
|
116
|
8otoB |
Sars-cov-2 nsp10-16 methyltransferase in complex with amp |
|
78
|
301
|
8okmA |
Crystal structure of f2f-2020197-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
90
|
301
|
8otoA |
Sars-cov-2 nsp10-16 methyltransferase in complex with amp |
|
77
|
301
|
8oklA |
Crystal structure of f2f-2020185-01x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
81
|
301
|
8oknA |
Crystal structure of f2f-2020198-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
86
|
306
|
8ej7A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
92
|
306
|
8dklA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dkhA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
81
|
306
|
8dmnA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
92
|
306
|
8dkkA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
100
|
297
|
8cgbA |
Monkeypox virus vp39 in complex with sah |
|
81
|
306
|
8djjA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
76
|
306
|
8eirA |
Sars-cov-2 polyprotein substrate regulates the stepwise mpro cleavage reaction |
|
79
|
306
|
8ej9A |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
74
|
306
|
8dkzA |
Polymorphism in sars-cov-2 nsp5 main protease reveals differences in cleavage of viral and host substrates |
|
59
|
305
|
8ekeA |
Cryo-em structure of sars cov-2 mpro wt protease |
|
88
|
304
|
5smlA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z68337194 (mpro-ibm0045) |
|
87
|
301
|
8hefA |
The crystal structure of deuterated s-217622 (ensitrelvir) bound to the main protease (3clpro/mpro) of sars-cov-2 |
|
91
|
304
|
5smmA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z1633315555 (mpro-ibm0058) |
|
90
|
304
|
5smnA |
Pandda analysis group deposition of sars-cov-2 main protease ligands identified from single sequence-guideddeep generative framework -- crystal structure of sars-cov-2 main protease in complex with z1365651030 (mpro-ibm0078) |
|
87
|
306
|
7sh8A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi88 |
|
86
|
306
|
7sh9A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi86 |
|
82
|
306
|
7sh7A |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi87 |
|
97
|
297
|
8ceqA |
Crystal structure of monkeypox virus methyltransferase vp39 in complex with inhibitor to427 |
|
99
|
297
|
8cesA |
Crystal structure of monkeypox virus methyltransferase vp39 in complex with inhibitor to500 |
|
97
|
297
|
8cetA |
Crystal structure of monkeypox virus methyltransferase vp39 in complex with inhibitor to507 |
